Session Details

The Role of GABAA Receptors in the Treatment of Panic Disorder

Wednesday, 11 February 2004 14:30 -16:00

Harbourside Meeting Room 3

This symposium is supported by Wyeth Germany and Bristol-Myers Squibb Germany.

Chairperson Dr Rainer Rupprecht Ludwig-Maximilian-University, MunichGermany
GABA neuronal function abnormalities associated with panic attacks and panic disorder assessed using 1H-MRS
  • John H Krystal, Yale University School of Medicine, United States
    • GABAA receptorα-1 subunit deletion elicits marked decreases om receptor assembly and alterations in pharmacological responses to Benzodiazepines
  • A Leslie Morrow, University of North Carolina, United States
    • Drugs targeting the GABA binding site and neuroactive steroids as new strategies for the treatment of panic disorder
  • Rainer Rupprecht, Ludwig-Maximilian-University, Munich, Germany
  • Peter Zwanzger, Ludwig-Maximilian-University, Munich, Germany
  • Andreas Ströhle, Max-Planck-Institute of Psychiatry, Munich, Germany
  • Elena Romeo, Tor Vergata University, Rome, Italy
    • The role of GABA-A receptors in the pathophysiology of panic disorder
  • David J Nutt, University of Bristol, United Kingdom